Cambridge, Mass.-based InVivo Therapeutics reported the sixth patient conversion in its INSPIRE study testing the Neuro-Spinal Scaffold.
Here are five observations:
1. The patient has improved, going from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury, between discharge and the one-month follow-up.
2. The study has now seen a 54.5 percent conversion rate among the 11 enrolled patients.
3. The patient enrolled in the INSPIRE study at Charlotte, N.C.-based Carolina Neurosurgery and Spine Associates/Carolinas Rehabilitation in December 2016.
4. Domagoj Coric, MD, and Samuel Chewning, MD, implanted the Neuro-Spinal Scaffold in the patient.
5. The INSPIRE study tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.